Lv31
316 积分 2024-05-27 加入
Aptamer-PROTAC Conjugates (APCs) for Tumor-Specific Targeting in Breast Cancer
4天前
已完结
Design, synthesis, and evaluation of PD-L1 degraders to enhance T cell killing activity against melanoma
4天前
已完结
PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity
4天前
已完结
The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodies
10天前
已完结
Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect
21天前
已完结
A Dual-Targeting Liposome Enhances Triple-Negative Breast Cancer Chemoimmunotherapy through Inducing Immunogenic Cell Death and Inhibiting STAT3 Activation
23天前
已完结
Programmable and Multifunctional DNA-Based Materials for Biomedical Applications
1个月前
已完结
Aptamer-Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy
1个月前
已完结
DNA tetrahedron-based nanogels for siRNA delivery and gene silencin
1个月前
已完结
Aptamer–Protein Interactions: From Regulation to Biomolecular Detection
1个月前
已完结
皖公网安备34019202002308
